Guillain-Barré Syndrome (GBS) is a rare but serious neurological disorder in which the body’s immune system mistakenly attacks the peripheral nerves (nerves outside the brain and spinal cord). It often leads to sudden muscle weakness, numbness, and in severe cases, paralysis.
GBS usually occurs after an infection, causing the immune system to become overactive and damage the protective covering (myelin) of the nerves. This disrupts communication between the brain and the body.
The exact cause of GBS is unknown, but it is often triggered by an infection. Common triggers include:
Bacterial infections, especially Campylobacter jejuni (often found in undercooked poultry)
Viral infections such as:
Rarely, it may occur after:
GBS is not contagious and does not spread from person to person.
Symptoms often begin suddenly and progress rapidly, typically reaching peak severity within 2 weeks. The hallmark signs include:
Early Symptoms:
As the condition worsens:
Symptoms usually peak in 1–2 weeks and then stabilize or begin to improve.
Diagnosis involves a combination of medical history, physical examination, and specialized tests:
Neurological Exam:
Lumbar Puncture (Spinal Tap):
Nerve Conduction Studies (NCS) and Electromyography (EMG):
There is no cure, but early treatment greatly improves recovery outcomes. Hospitalization is usually required.
Main Treatments:
Immunotherapy
Supportive Care
Rehabilitation
Guillain-Barré Syndrome is a rare but treatable neurological emergency. Early diagnosis, immediate treatment, and ongoing rehabilitation play a critical role in recovery. With the right care, most patients regain function and return to a normal or near-normal life.